Genetic aberrations in gliomatosis cerebri

Neurosurgery

Volumn 60, Issue 1, 2007, Pages 150-158

  Ware, Marcus L ^a,e   Hirose, Yuichi ^b   Scheithauer, Bernd W ^c   Yeh, Ru Fang ^a   Mayo, Mary C ^d   Smith, Justin S ^a   Chang, Susan ^a   Cha, Soonmee ^d   Tihan, Tarik ^a   Feuerstein, Burt G ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KEIO UNIVERSITY   (Japan)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Array comparative genomic hybridization; Brain tumor; Degenerate oligonucleotide primed polymerase chain reaction; Diffuse astrocytomas; Gliomatosis cerebri

Indexed keywords

DNA; OLIGONUCLEOTIDE; TEMOZOLOMIDE;

ADULT; ANAMNESIS; BRAIN BIOPSY; CHROMOSOME 10Q; CHROMOSOME 13Q; CHROMOSOME 7Q; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE COURSE; DNA DETERMINATION; EVALUATION; FEMALE; GLIOSIS; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MALE; MEDICAL SCHOOL; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RADIATION; REVIEW; STATISTICAL SIGNIFICANCE; SURVIVAL; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGED; BRAIN NEOPLASMS; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, NEUROEPITHELIAL; NUCLEIC ACID HYBRIDIZATION; RETROSPECTIVE STUDIES;

EID: 33846218703     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000249203.73849.5D     Document Type: Review

References (44)

1. Arslantas A, Artan S, Oner U, Muslumanoglu H, Durmaz R, Cosan E, Atasoy MA, Basaran N, Tel E: The importance of genomic copy number changes in the prognosis of glioblastoma multiforme. Neurosurg Rev 27:58-64, 2004.
2. Artigas J, Cervos-Navarro J, Iglesias JR, Ebhardt G: Gliomatosis cerebri: Clinical and histological findings. Clin Neuropathol 4:135-148, 1985.
3. Backlund LM, Nilsson BR, Goike HM, Schmidt EE, Liu L, Ichimura K, Collins VP: Short postoperative survival for glioblastoma patients with a dysfunctional Rb1 pathway in combination with no wild-type PTEN. Clin Cancer Res 9:4151-4158, 2003.
4. Bindal AK, Hammoud M, Shi WM, Wu SZ, Sawaya R, Rao JS: Prognostic significance of proteolytic enzymes in human brain tumors. J Neurooncol 22:101-110, 1994.
5. Buckner JC: Factors influencing survival in high-grade gliomas. Semin Oncol 30:10-14, 2003.
6. Cohen-Gadol AA, DiLuna ML, Bannykh SI, Piepmeier JM, Spencer DD: Non-enhancing de novo glioblastoma: Report of two cases. Neurosurg Rev 27:281-285, 2004.
7. Couch JR, Weiss SA: Gliomatosis cerebri. Report of four cases and review of the literature. Neurology 24:504-511, 1974.
8. Cozad SC, Townsend P, Morantz RA, Jenny AB, Kepes JJ, Smalley SR: Gliomatosis cerebri. Results with radiation therapy. Cancer 78:1789-1793, 1996.
9. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P: Grading of astrocytomas. A simple and reproducible method. Cancer 62:2152-2165, 1988.
10. Davies RL, Grosse VA, Kucherlapati R, Bothwell M: Genetic analysis of epidermal growth factor action: Assignment of human epidermal growth factor receptor gene to chromosome 7. Proc Natl Acad Sci U S A 77:4188-4192, 1980.
11. Elshaikh MA, Stevens GH, Peereboom DM, Cohen BH, Prayson RA, Lee SY, Barnett GH, Suh JH: Gliomatosis cerebri: Treatment results with radiotherapy alone. Cancer 95:2027-2031, 2002.
12. Hecht BK, Turc-Carel C, Chatel M, Lonjon M, Roche JL, Gioanni J, Hecht F, Gaudray P: Chromosomes in gliomatosis cerebri. Genes Chromosomes Cancer 14:149-153, 1995.
13. Herrlinger U, Felsberg J, Kuker W, Bornemann A, Plasswilm L, Knobbe CB, Strik H, Wick W, Meyermann R, Dichgans J, Bamberg M, Reifenberger G, Weller M: Gliomatosis cerebri: Molecular pathology and clinical course. Ann Neurol 52:390-399, 2002.
14. Hilton DA, Penney M, Evans B, Sanders H, Love S: Evaluation of molecular markers in low-grade diffuse astrocytomas: Loss of p16 and retinoblastoma protein expression is associated with short survival. Am J Surg Pathol 26:472-478, 2002.
15. Hilton DA, Penney M, Pobereskin L, Sanders H, Love S: Histological indicators of prognosis in glioblastomas: Retinoblastoma protein expression and oligodendroglial differentiation indicate improved survival. Histopathology 44:555-560, 2004.
16. Hirose Y, Aldape K, Takahashi M, Berger MS, Feuerstein BG: Tissue microdissection and degenerate oligonucleotide primed-polymerase chain reaction (DOP-PCR) is an effective method to analyze genetic aberrations in invasive tumors. J Mol Diagn 3:62-67, 2001.
17. Inda MM, Fan X, Munoz J, Perot C, Fauvet D, Danglot G, Palacio A, Madero P, Zazpe I, Portillo E, Tunon T, Martinez-Penuela JM, Alfaro J, Eiras J, Bernheim A, Castresana JS: Chromosomal abnormalities in human glioblastomas: Gain in chromosome 7p correlating with loss in chromosome 10q. Mol Carcinog 36:6-14, 2003.
18. Jennings MT, Frenchman M, Shehab T, Johnson MD, Creasy J, LaPorte K, Dettbarn WD: Gliomatosis cerebri presenting as intractable epilepsy during early childhood. J Child Neurol 10:37-45, 1995.
19. Kim DH, Mohapatra G, Bollen A, Waldman FM, Feuerstein BG: Chromosomal abnormalities in glioblastoma multiforme tumors and glioma cell lines detected by comparative genomic hybridization. Int J Cancer 60:812-819, 1995.
20. Kim DG, Yang HJ, Park IA, Chi JG, Jung HW, Han DH, Choi KS, Cho BK: Gliomatosis cerebri: clinical features, treatment, and prognosis. Acta Neurochir (Wien) 140:755-762, 1998.
21. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK: The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215-229, 2002.
22. Lopez-Gines C, Cerda-Nicolas M, Gil-Benso R, Pellin A, Lopez-Guerrero JA, Callaghan R, Benito R, Roldan P, Piquer J, Llacer J, Barbera J: Association of chromosome 7, chromosome 10 and EGFR gene amplification in glioblastoma multiforme. Clin Neuropathol 24:209-218, 2005.
23. Maier D, Zhang Z, Taylor E, Hamou MF, Gratzl O, Van Meir EG, Scott RJ, Merlo A: Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas. Oncogene 16:3331-3335, 1998.
24. Mawrin C, Kirches E, Schneider-Stock R, Scherlach C, Vorwerk C, Von Deimling A, Van Landeghem F, Meyermann R, Bornemann A, Muller A, Romeike B, Stoltenburg-Didinger G, Wickboldt J, Pilz P, Dietzmann K: Analysis of TP53 and PTEN in gliomatosis cerebri. Acta Neuropathol (Berl) 105:529-536, 2003.
25. Mawrin C, Schneider T, Firsching R, Wiedemann FR, Dietzmann K, Bornemann A, Romeike BF, Sellhaus B, von Deimling A: Assessment of tumor cell invasion factors in gliomatosis cerebri. J Neurooncol 73:109-115, 2005.
26. Moghrabi A, Kerby T, Tien RD, Friedman HS: Prognostic value of contrast-enhanced magnetic resonance imaging in brainstem gliomas. Pediatr Neurosurg 23:293-298, 1995.
27. Moriyama T, Kataoka H, Koono M, Wakisaka S: Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: Evidence for a role in progression of astrocytic tumors (review). Int J Mol Med 3:531-536, 1999.
28. Nabeshima K, Shimao Y, Sato S, Kataoka H, Moriyama T, Kawano H, Wakisaka S, Koono M: Expression of c-Met correlates with grade of malignancy in human astrocytic tumours: An immunohistochemical study. Histopathology 31:436-443, 1997.
29. Ohgaki H, Kleihues P: Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64:479-489, 2005.
30. Perkins GH, Schomer DF, Fuller GN, Allen PK, Maor MH: Gliomatosis cerebri: Improved outcome with radiotherapy. Int J Radiat Oncol Biol Phys 56:1137-1146, 2003.
31. Plathow C, Lichy MP, Bachert P, Zuna I, Kauczor HU: The role of MRI in patients with astrocytoma WHO II treated with fractionated stereotactic radiotherapy. Eur Radiol 14:679-685, 2004.
32. Sanson M, Cartalat-Carel S, Taillibert S, Napolitano M, Djafari L, Cougnard J, Gervais H, Laigle F, Carpentier A, Mokhtari K, Taillandier L, Chinot O, Duffau H, Honnorat J, Hoang-Xuan K, Delattre JY: Initial chemotherapy in gliomatosis cerebri. Neurology 63:270-275, 2004.
33. Scott JN, Brasher PM, Sevick RJ, Rewcastle NB, Forsyth PA: How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology 59:947-949, 2002.
34. Sherr CJ, McCormick F: The RB and p53 pathways in cancer. Cancer Cell 2:103-112, 2002.
35. Smith JS, Chang SM, Lamborn KR, Prados MD, Berger MS, Vates GE: Gliomatosis Cerebri, in Berger MS, Prados MD (eds): Textbook of Neuro-Oncology. Philadephia, Elsevier, 2005, pp 211-217.
36. Smith JS, Jenkins RB: Genetic alterations in adult diffuse glioma: Occurrence, significance, and prognostic implications. Front Biosci 5:D213-D231, 2000.
37. Stewart CL, Soria AM, Hamel PA: Integration of the pRB and p53 cell cycle control pathways. J Neurooncol 51:183-204, 2001.
38. Stupp R, Janzer RC, Hegi ME, Villemure JG, Mirimanoff RO: Prognostic factors for low-grade gliomas. Semin Oncol 30:23-28, 2003.
39. Tancredi A, Mangiola A, Guiducci A, Peciarolo A, Ottaviano P: Oligodendrocytic gliomatosis cerebri. Acta Neurochir (Wien) 142:469-472, 2000.
40. Vates GE, Chang S, Lamborn KR, Prados M, Berger MS: Gliomatosis cerebri: A review of 22 cases. Neurosurgery 53:261-271, 2003.
41. Wernicke C, Thiel G, Lozanova T, Vogel S, Witkowski R: Numerical aberrations of chromosomes 1, 2, and 7 in astrocytomas studied by interphase cytogenetics. Genes Chromosomes Cancer 19:6-13, 1997.
42. Wessels PH, Twijnstra A, Kessels AG, Krijne-Kubat B, Theunissen PH, Ummelen MI, Ramaekers FC, Hopman AH: Gain of chromosome 7, as detected by in situ hybridization, strongly correlates with shorter survival in astrocytoma grade 2. Genes Chromosomes Cancer 33:279-284, 2002.
43. Wessels PH, Weber WE, Raven G, Ramaekers FC, Hopman AH, Twijnstra A: Supratentorial grade II astrocytoma: Biological features and clinical course. Lancet Neurol 2:395-403, 2003.
44. Xiao A, Wu H, Pandolfi PP, Louis DN, Van Dyke T: Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation. Cancer Cell 1:157-168, 2002.